MYUNGMOON Pharm co.,Ltd

₩1,104As of Sun 8 Nov 2026, 12:00 UTC
KRX:017180Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (11.98%)
Div yield —
ROE (2.48%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.25
PE TTM —
TSR TTM (30.43%)
Mkt cap ₩36.90B
ROIC 0.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,145
3.68%
(28.03%)
Buy 7|0|7|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
14.37
15.76
17.62
18.09
8.99%
12.15%
22.42%
21.57%
Revenue₩B
3.558
3.723
3.740
3.777
0.51%
8.18%
10.93%
8.39%
Peers (US$27.21M)
Cap (US$)
PE
46.63M
2.890x
43.25M
5.361x
Capital
TTM
5Y
10Y
Leveragex
0.160
0.555
0.497
EBIT/Intx
0.579
0.179
0.183
Own earn%
(20.66)
(14.33)
(22.08)
Sh yield%
29.71
66.81
62.80
Owners
Insiders/Inst%
8.40
51.92
Short interest%
3.85
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–21
$1 testx
—
Incr. ROIC%
54